Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Giant Cell Arteritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06281236
What this trial is testing

A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)

Who this might be right for
Polymyalgia Rheumatica
Sparrow Pharmaceuticals 1
Not applicableNot Yet RecruitingNCT07628075
What this trial is testing

Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.

Who this might be right for
Large Vessel VasculitisTakayasu ArteritisGiant Cell Arteritis (GCA)
Imperial College London 18
Not applicableLooking for participantsNCT05854927
What this trial is testing

Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)

Who this might be right for
Giant Cell Arteritis
Fondation Ophtalmologique Adolphe de Rothschild 133
Large-scale testing (Phase 3)Looking for participantsNCT07279688
What this trial is testing

Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica

Who this might be right for
Polymyalgia Rheumatica (PMR)
University Hospital, Brest 140
Not applicableEnded earlyNCT04335747
What this trial is testing

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+2 more
Salome Kristensen 53
Not applicableLooking for participantsNCT04102930
What this trial is testing

Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

Who this might be right for
Giant Cell ArteritisPolymyalgia Rheumatica
University of Leeds 4,500
Large-scale testing (Phase 3)Not Yet RecruitingNCT06833411
What this trial is testing

Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone

Who this might be right for
Giant Cell Arteritis (GCA)
Insel Gruppe AG, University Hospital Bern 178
Testing effectiveness (Phase 2)Study completedNCT03812302
What this trial is testing

Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)

Who this might be right for
Giant Cell Arteritis
University of Alberta 9
Not applicableStudy completedNCT02190942
What this trial is testing

VCRC Patient Contact Registry Patient-Reported Data Validation Study

Who this might be right for
Behcet's DiseaseChurg-Strauss SyndromeGiant Cell Arteritis+4 more
University of South Florida 198
Testing effectiveness (Phase 2)Study completedNCT01910038
What this trial is testing

Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.

Who this might be right for
Giant Cell Arteritis
Centre Hospitalier Universitaire Dijon 20
Not applicableActive Not RecruitingNCT04519580
What this trial is testing

Improved Diagnostics and Monitoring of Polymyalgia Rheumatica

Who this might be right for
Polymyalgia RheumaticaGiant Cell ArteritisAdrenal Insufficiency
Kresten Krarup Keller 98
Testing effectiveness (Phase 2)Ended earlyNCT05168475
What this trial is testing

Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis

Who this might be right for
Giant Cell ArteritisTakayasu ArteritisCogan Syndrome+6 more
Cambridge University Hospitals NHS Foundation Trust 22
Not applicableUnknownNCT01066208
What this trial is testing

American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis

Who this might be right for
Wegener's GranulomatosisMicroscopic PolyangiitisChurg Strauss Syndrome+3 more
University of Oxford 3,588
Not applicableUnknownNCT04397237
What this trial is testing

Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe

Who this might be right for
COVID-19Systemic Lupus ErythematosusSjogren's Syndrome+3 more
Pitié-Salpêtrière Hospital 3,100
Not applicableNot Yet RecruitingNCT07737470
What this trial is testing

Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research

Who this might be right for
PericarditisTako-TSUBO CardiomyopathyMyocarditis+12 more
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Ended earlyNCT04972968
What this trial is testing

Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

Who this might be right for
Polymyalgia Rheumatica
AbbVie 181
Testing effectiveness (Phase 2)Study completedNCT05436652
What this trial is testing

A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)

Who this might be right for
Polymyalgia Rheumatica
Sparrow Pharmaceuticals 66
Large-scale testing (Phase 3)Study completedNCT00430807
What this trial is testing

Hydroxychloroquine in Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
University Hospital, Toulouse 75
Not applicableNot Yet RecruitingNCT07508514
What this trial is testing

Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA

Who this might be right for
Giant Cell ArteritisTemporal ArteritisOptic Nerve Diseases+1 more
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 60
Testing effectiveness (Phase 2)Study completedNCT03482479
What this trial is testing

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (EGPA)Churg-Strauss Syndrome (CSS)Giant Cell Arteritis+4 more
University of Pennsylvania 60
Next Page